Zhijian Lu,Yi-Heng Chen,Cameron Smith,Hong Li,Christopher F. Thompson,Julianne Hunt,Florida Kallashi,Ramzi Sweis,Peter Sinclair,Samantha E. Adamson,Guizhen Dong,Debra L. Ondeyka,Xiaoxia Qian,Wanying S
申请号：
US13881896
公开号：
US09221834B2
申请日:
2011.10.25
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, A3 is a substituted phenyl group or indanyl group. Formula (I).
